Testing this tool

Patient Journey One of the stated goals of ALK is to have AIT initiated earlier in the patient journey. At present, AIT is the last step. Patients often arrive at the allergist after years of trying over the counter meds or prescription nasal steroids (INCS) that do not provide adequate relief.

Target Audience As stated, the target audience for allergy.ca is patients in Canada who suffer from allergic rhinitis who are dissatisfied with conventional treatment because they continue to experience inadequate control on traditional treatments and who therefore continue to suffer from the symptoms associated with allergic rhinitis. Inadequate control is measured by breakthrough symptoms for patients who are taking traditional pharmacotherapy for their allergies (over the counter antihistamines, Intranasal Corticosteroids, Eye Drops, OTC Sprays/decongestants, holistic remedies, SCIT or SLIT drops)